NEUROBO PHARMACEUTICALS INC's ticker is NRBO and the CUSIP is 64132R107. A total of 26 filers reported holding NEUROBO PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Mount Yale Investment Advisors, LLC | 57,425 | $214,000 | 0.02% |
| UBS Group AG | 1,037 | $4,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 371 | $1,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 323 | $1,000 | 0.00% |
| NORTHERN TRUST CORP | 24,642 | $92,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 728 | $3,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 60,792 | $226,000 | 0.00% |
| STATE STREET CORP | 15,878 | $59,000 | 0.00% |
| MORGAN STANLEY | 141 | $0 | 0.00% |